-
Oxford Nanopore Announces New Pores, Kits and Updates on Projects
Bio-IT World | The Chief Technology Officer at Oxford Nanopore gave a technical Oxford Nanopore update this morning, outlining updates on MinION, PromethION, SmidgeION, hardware and chemistries.
Sep 29, 2016
-
Cloud Pharmaceuticals, Rubicon Genomics, Bioz and more: News from September 2016
Bio-IT World News Briefs | News, products, and partnerships from around the bio-IT community including news from Cloud Pharmaceuticals, Rubicon Genomics, Bioz, and more.
Sep 29, 2016
-
Despite the Hype Over Gene Therapy Few Drugs Are Close to Approval
MIT Technology Review | There are hundreds of early clinical trials, but only a handful of late-stage ones have reached completion.
Sep 29, 2016
-
Why Big Pharma Wants To Collect 2 Million Genomes
Nature News & Comment | For the head of AstraZeneca's genomics initiative, the challenge is not just getting the sequences, but in putting them to use - wisely.
Sep 28, 2016
-
Microsoft Goes All in for FPGAs to Build Out AI Cloud
TOP500 Supercomputer Sites | Microsoft has revealed that Altera FPGAs have been installed across every Azure cloud server, creating what the company is calling "the world's first AI supercomputer."
Sep 28, 2016
-
Addressing Common Roadblocks In Drug Development: Keynotes At 2016 Discovery On Target
Bio-IT World | There is tremendous unlocked potential for new therapeutic drugs. Some of the key aspects of drug development were addressed with novel solutions in compelling plenary keynote talks at the 2016 Discovery on Target Conference in Boston last week.
Sep 28, 2016
-
Color Genomics Raises $45 Million To Expand Genetic Testing
Bloomberg | Color Genomics Inc., the three-year-old startup aiming to democratize genetic testing, sealed $45 million in funding as it seeks to make its tests for cancer more affordable and accessible, the company announced Tuesday.
Sep 27, 2016
-
Kite Unveils Anticipated CAR-T Cancer Data Positive But Not Complete
Xconomy | Kite Pharma has dipped into a highly anticipated clinical trial of its cancer treatment, KTE-C19, to release a partial set of data. Although not complete, the data bolster the view that Kite could be the first among its peers to win the FDA's green light.
Sep 27, 2016
-
The Sequencing App and the Quest for Fun
Bio-IT World | The latest way to get into your genome is a $50 app-based venture that promises to give you a peek into your ancestry and tell you what kinds of bacteria you’re harboring in your mouth. Seeq launched earlier this month offering ultra-low coverage sequencing of the genome, oral microbiome sequencing, and ancestry reports. The goal is an extremely inexpensive infrastructure for people to get a little bit of genomic data and participate in research in a way that’s easy and fun.
Sep 26, 2016
